Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic arm brace could restore movement in chronic stroke patients

NCT ID NCT05296408

Recruiting now Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a wearable robotic arm device called MyoPro, combined with motor learning therapy, can improve arm function in people who had a stroke at least six months ago and have severe arm weakness. The device reads muscle signals to help move the arm. Sixty participants will be randomly assigned to receive either therapy with the device or therapy alone. The goal is to see if the device leads to better arm movement and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MyoPro myoelectric orthosis (wearable robotic arm device) plus motor learning-based therapy
What this could lead to
If successful, this could provide a new way to help people with long-term severe arm weakness after stroke regain some movement and independence.
What could go wrong
This is an early-stage study with only 60 participants, so results may not apply to everyone. The device requires detectable muscle signals, which not all stroke survivors have.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC STROKE

Contacts and locations

Locations

  • Louis Stokes VA Medical Center, Cleveland, OH

    RECRUITING

    Cleveland, Ohio, 44106-1702, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.